ストックスクリーナーアプリを入手
21.07
2.98%
0.61
アフターアワーズ：
21.40
0.33
+1.57%
Bioage Labs Inc (BIOA) 最新ニュース
Market Trends: How does BioAge Labs Inc perform in inflationary periodsTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
BioAge Investors Lose Last Bid At Obesity Drug-Linked Suit - Law360
BioAge Labs (NASDAQ: BIOA) CMO exercises options, sells 7,433 shares in 10b5-1 trade - Stock Titan
[Form 4] BioAge Labs, Inc. Insider Trading Activity - Stock Titan
BioAge Labs (NASDAQ:BIOA) Shares Gap DownHere's Why - MarketBeat
Risk Analysis: How does BioAge Labs Inc perform in inflationary periods2025 Performance Recap & Community Driven Trade Alerts - baoquankhu1.vn
Investment Recap: How do insiders feel about BioAge Labs Inc2025 Geopolitical Influence & Weekly High Return Stock Opportunities - baoquankhu1.vn
BIOA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update - MarketBeat
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BI - GuruFocus
BioAge Labs Touts Oral NLRP3 Inhibitor BGE-102 Data, Eyes CV Study and Retinal Expansion - Yahoo Finance
Oppenheimer Begins Coverage on BioAge Labs (NASDAQ:BIOA) - MarketBeat
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Oppenheimer Initiates Coverage of BioAge Labs (BIOA) with Outperform Recommendation - Nasdaq
BioAge Labs: Differentiated NLRP3 Inhibitor BGE-102 Positions Company for Best-in-Class Cardiometabolic Upside and Strategic M&A Appeal - TipRanks
BioAge Labs (BIOA) Price Target Increased by 10.09% to 30.60 - Nasdaq
Oppenheimer initiates BioAge Labs stock coverage with outperform rating By Investing.com - Investing.com Canada
Oppenheimer initiates BioAge Labs stock coverage with outperform rating - Investing.com
Technical Analysis: Is BioAge Labs Inc backed by strong institutional buyingQuarterly Portfolio Review & Capital Efficiency Focused Ideas - baoquankhu1.vn
Fed Watch: Whats the beta of BioAge Labs Inc stock2025 Market Sentiment & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget
BioAge Labs, Inc. (BIOA) Receives Buy Rating From Jefferies With Significant Upside Potential - 富途牛牛
Jefferies upgrades BioAge Labs stock rating on drug potential By Investing.com - Investing.com Nigeria
This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Jefferies Upgrades BioAge Labs (BIOA) - Nasdaq
Jefferies upgrades BioAge Labs stock rating on drug potential - Investing.com
Should You Buy BIOAGE Labs Inc (BIOA) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Down 16.3% in January - MarketBeat
Is BioAge Labs Inc.’s ROE strong enough2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - mfd.ru
Will BioAge Labs Inc. stock hit new highs in YEARQuarterly Portfolio Review & AI Forecasted Stock Moves - mfd.ru
Will BioAge Labs Inc. stock deliver long term returnsWatch List & Weekly Breakout Watchlists - mfd.ru
How BioAge Labs Inc. stock benefits from tech adoptionEarnings Trend Report & Real-Time Volume Triggers - mfd.ru
Whale Trades: What is Columbia Sportswear Companys P E ratio telling usJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
Returns Recap: Is BioAge Labs Inc a good stock for dollar cost averagingJuly 2025 Technicals & Consistent Profit Trade Alerts - baoquankhu1.vn
Can BioAge Labs Inc. lead its sector in growthJuly 2025 Weekly Recap & Expert Verified Stock Movement Alerts - mfd.ru
BioAge Labs (NASDAQ:BIOA) Trading Down 5.6%Here's What Happened - MarketBeat
Can BioAge Labs Inc. stock hit analyst price targetsWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru
S P Trends: Whats the beta of BioAge Labs Inc stockShare Buyback & Consistent Return Investment Signals - baoquankhu1.vn
BioAge Labs (BIOA) Price Target Increased by 127.08% to 27.80 - Nasdaq
Morgan Stanley Boosts Price Target on BioAge Labs to $23 From $12, Keeps Equalweight Rating - marketscreener.com
BioAge Labs (NASDAQ:BIOA) Insider Sells $139,368.75 in Stock - MarketBeat
BioAge Labs (NASDAQ:BIOA) Upgraded at Wall Street Zen - MarketBeat
BioAge Labs (NASDAQ:BIOA) Trading 8% HigherHere's Why - MarketBeat
Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential - Pharma Voice
BioAge Labs Completes $115 Million Upsized Public Offering - Global Legal Chronicle
Piper Sandler Initiates Coverage of BioAge Labs (BIOA) with Overweight Recommendation - Nasdaq
BioAge Labs (NASDAQ:BIOA) Shares Gap UpShould You Buy? - MarketBeat
Piper Sandler Initiates BioAge Labs at Overweight With $73 Price Target - marketscreener.com
BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating - TipRanks
BioAge Labs stock initiated with Overweight rating by Piper Sandler - Investing.com UK
BioAge Labs (NASDAQ:BIOA) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Fenwick Represents BioAge Labs in $115M Upsized Public Offering - fenwick.com
Aug PreEarnings: Should you avoid PepsiCo Inc stock right nowEarnings Summary Report & Consistent Profit Trading Strategies - baoquankhu1.vn
BioAge Labs prices upsized stock offering of $115M - MSN
0.21%
1.77%
大文字化:
|
ボリューム (24 時間):